المؤلفون: Sean Duffy, Gerard J. Criner

المصدر: Current Medical Research and Opinion. 37:275-284

مصطلحات موضوعية: medicine.medical_specialty, Pulmonary disease, 030204 cardiovascular system & hematology, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, Tiotropium Bromide, biology, business.industry, Olodaterol, Tiotropium-olodaterol, Muscarinic antagonist, General Medicine, Lama, biology.organism_classification, Benzoxazines, Drug Combinations, chemistry, Clinical evidence, Quality of Life, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec7994b368dd20d12a3f250d924f7fcTest
https://doi.org/10.1080/03007995.2020.1841615Test

المؤلفون: Kenneth R. Chapman, Dave Singh, Robert A. Wise, Anthony D'Urzo, James F. Donohue

المصدر: Expert review of respiratory medicine. 15(9)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.drug_class, Pharmacology, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Aclidinium bromide, Bronchodilator, Formoterol Fumarate, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Adrenergic beta-2 Receptor Agonists, COPD, biology, business.industry, Public Health, Environmental and Occupational Health, Muscarinic antagonist, Lama, biology.organism_classification, medicine.disease, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, Quality of Life, Formoterol, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97eea6d61734bd5386c435985666671Test
https://pubmed.ncbi.nlm.nih.gov/34137664Test

المؤلفون: Gary T. Ferguson, Alberto de la Hoz, Peter M.A. Calverley, Marc Miravitlles, Wenqiong Xue

المصدر: COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Male, Muscarinic Antagonists, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Maintenance therapy, Adrenal Cortex Hormones, Forced Expiratory Volume, Bronchodilation, Administration, Inhalation, medicine, Steroid free, Humans, 030212 general & internal medicine, Tiotropium Bromide, Aged, COPD, biology, business.industry, Tiotropium-olodaterol, Muscarinic antagonist, Lama, Middle Aged, biology.organism_classification, medicine.disease, respiratory tract diseases, Benzoxazines, Bronchodilator Agents, Drug Combinations, Dual bronchodilation, Treatment Outcome, 030228 respiratory system, Anesthesia, Female, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11b801e07fa37052b83afc71c45792eTest
https://pubmed.ncbi.nlm.nih.gov/32928003Test

المؤلفون: Andrea Serafini, Elisa Petrucci, Alberto Ricci, Paola Rogliani, Fabio Lena, Antonio Perrella, Raffaele Scala, Marco Scalese, Andrea Montagnani, Leonardo Gianluca Lacerenza, Bruno Sposato, Alberto Cresti, Massimo Alessandri

المصدر: Pulmonary Pharmacology & Therapeutics. 71:102076

مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Fixed-dose combination, Salbutamol, LABA, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, Internal medicine, Administration, Inhalation, Settore MED/10, medicine, Humans, COPD, Pharmacology (medical), Adrenergic beta-2 Receptor Agonists, Retrospective Studies, Systemic corticosteroid, biology, business.industry, Biochemistry (medical), Olodaterol, Antibiotic, LAMA, Exacerbation, Lama, biology.organism_classification, medicine.disease, Glycopyrrolate, Bronchodilator Agents, Long-acting muscarinic antagonist, Drug Combinations, Treatment Outcome, chemistry, Long-acting β2-agonists, Indacaterol, Female, Formoterol, Vilanterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d915c4b6dc834da9ef276ae1df28bdTest
https://doi.org/10.1016/j.pupt.2021.102076Test

المؤلفون: Luigino Calzetta, Paola Rogliani, Mario Cazzola, Maria Gabriella Matera

المساهمون: Calzetta, Luigino, Matera, Maria Gabriella, Cazzola, Mario, Rogliani, Paola

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Long-acting β2-agonist, Pharmacology, law.invention, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, Randomized controlled trial, law, Forced Expiratory Volume, Pulmonary Medicine, Settore MED/10, Pharmacology (medical), COPD, biology, Brief Report, Olodaterol, Human isolated airways, Fixed-dose combination, General Medicine, Lama, Middle Aged, humanities, Respiratory Function Tests, Bronchodilator Agents, Synergy, Drug Combinations, Treatment Outcome, Respiratory, Female, Drug Monitoring, Respiratory/pulmonary, medicine.drug, Chronic Obstructive, Combination therapy, Drug development, Muscarinic Antagonists, Pulmonary Disease, Double-Blind Method, medicine, Humans, LABA/LAMA combination, Tiotropium Bromide, Triple therapy, Adrenergic beta-2 Receptor Agonists, Asthma, Aged, Dose-Response Relationship, Drug, business.industry, Dose-finding, Muscarinic antagonist, medicine.disease, biology.organism_classification, Human isolated airway, respiratory tract diseases, Benzoxazines, Long-acting muscarinic antagonist, chemistry, Commentary, business, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e8233fcbdbea458e82d3960e470a5eTest
http://hdl.handle.net/2108/262688Test

المؤلفون: Rabe, K. F., Martinez, F. J., Ferguson, G. T., Wang, C., Singh, D., Wedzicha, J. A., Trivedi, R., t. Rose E., S, Ballal, S., Mclaren, J., Darken, P., Aurivillius, M., Reisner, C., Dorinsky, P., Spanevello, A.

المصدر: Rabe, K F, Martinez, F J, Ferguson, G T, Wang, C, Singh, D, Wedzicha, J A, Trivedi, R, St. Rose, E, Ballal, S, Mclaren, J, Darken, P, Aurivillius, M, Reisner, C & Dorinsky, P 2020, ' Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD ', New England Journal Of Medicine, vol. 383, no. 1, pp. 35-48 . https://doi.org/10.1056/NEJMoa1916046Test

مصطلحات موضوعية: Male, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Gastroenterology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Forced Expiratory Volume, Formoterol Fumarate, 80 and over, Medicine, 030212 general & internal medicine, Budesonide, 11 Medical and Health Sciences, Inhalation, biology, General Medicine, Lama, Middle Aged, Intention to Treat Analysis, Drug Combinations, Administration, Female, hormones, hormone substitutes, and hormone antagonists, Glucocorticoid, medicine.drug, Adult, medicine.medical_specialty, Chronic Obstructive, Muscarinic Antagonists, Severe copd, Pulmonary Disease, 03 medical and health sciences, Double-Blind Method, Internal medicine, General & Internal Medicine, Humans, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Aged, Intention-to-treat analysis, business.industry, Administration, Inhalation, Aged, 80 and over, Glycopyrrolate, Pulmonary Disease, Chronic Obstructive, Muscarinic antagonist, biology.organism_classification, Multicenter study, ETHOS Investigators, business

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df6acf5d9a0dcfc420dc8a0e8f3fa8fTest
http://hdl.handle.net/11383/2132038Test

المؤلفون: John H. Riley, Ian Naya, Neil Barnes, Lee Tombs, Ana R. Sousa, Bernardino Alcázar Navarrete, Sadhana Patel, Gregory J. Feldman, David A. Lipson, Chris Compton

المساهمون: [Feldman, Gregory J.] S Carolina Pharmaceut Res, Spartanburg, SC 29303 USA, [Sousa, Ana R.] GlaxoSmithKline, Resp Res & Dev, Stockley Pk West, Uxbridge, Middx, England, [Lipson, David A.] GlaxoSmithKline, Resp Res & Dev, King Of Prussia, PA USA, [Lipson, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA, [Tombs, Lee] Precise Approach Ltd, Birmingham, W Midlands, England, [Barnes, Neil] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Patel, Sadhana] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Compton, Chris] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Riley, John H.] GlaxoSmithKline, GlaxoSmithKline Med Res Ctr, Resp Therapy Area Unit, Stevenage, Herts, England, [Naya, Ian] GlaxoSmithKline, Resp Med, Brentford, Middx, England, [Alcazar Navarrete, Bernardino] Hosp Alta Resoluc Loja, Neumol, Granada, Spain, GlaxoSmithKline

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Quinuclidines, Respimat, Long-acting β2-agonist, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Forced Expiratory Volume, Medicine, Pharmacology (medical), Vilanterol, 030212 general & internal medicine, Original Research, education.field_of_study, COPD, Cross-Over Studies, Olodaterol, LAMA, Double-blind, General Medicine, Middle Aged, Dry-powder inhaler, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Anesthesia, Combination, Long-acting beta 2-agonist, Female, Bronchodilation, Safety, Moderate, Population, LABA, Chlorobenzenes, 03 medical and health sciences, Bronchodilators, Double-Blind Method, Administration, Inhalation, Humans, Umeclidinium, Tiotropium Bromide, education, Benzyl Alcohols, Dynamic hyperinflation, Aged, business.industry, Nebulizers and Vaporizers, Tiotropium, medicine.disease, Confidence interval, Benzoxazines, Long-acting muscarinic antagonist, 030228 respiratory system, chemistry, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa4d2adec229bf9ad2d05d732898175Test
https://doi.org/10.1007/s12325-017-0626-4Test

المؤلفون: Syed Mohammad Tariq, Enson C Thomas

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, Time Factors, Fixed-dose combination, Review, Muscarinic Antagonists, Placebo, inhaled corticosteroid, Maintenance Chemotherapy, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, exacerbations, Maintenance therapy, Adrenal Cortex Hormones, Forced Expiratory Volume, Administration, Inhalation, medicine, COPD, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Intensive care medicine, Adverse effect, Adrenergic beta-2 Receptor Agonists, Lung, biology, business.industry, Nebulizers and Vaporizers, General Medicine, Lama, medicine.disease, biology.organism_classification, Bronchodilator Agents, Clinical trial, long-acting beta-agonist, Drug Combinations, Treatment Outcome, 030228 respiratory system, Disease Progression, Physical therapy, dual bronchodilation, business, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8d9a80a1cc15eccfe7b4ff2e707c20Test
https://doi.org/10.2147/copd.s138006Test

المؤلفون: David Price, Pablo Altman, Konstantinos Kostikas, Gustavo J Rodrigo, Dave Singh, Antonio Anzueto, Francesco Patalano, Robert Fogel, Giovanni Bader

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Time Factors, law.invention, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, Adrenal Cortex Hormones, Risk Factors, law, Forced Expiratory Volume, Bronchodilator, Odds Ratio, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, COPD, biology, LAMA, General Medicine, LABA/LAMA combinations, Lama, LABA/ICS, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Meta-analysis, Disease Progression, Corticosteroid, hormones, hormone substitutes, and hormone antagonists, medicine.drug, medicine.medical_specialty, medicine.drug_class, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Adrenergic beta-2 Receptor Agonists, Chi-Square Distribution, business.industry, Muscarinic antagonist, Recovery of Function, medicine.disease, biology.organism_classification, meta-analysis, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a515da86325caefef02d3fb52b133eTest
https://doi.org/10.2147/copd.s130482Test

المؤلفون: James F. Donohue, Anthony D'Urzo, Kenneth R. Chapman, Dave Singh

المصدر: Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 13 (2019)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Fixed-dose combination, formoterol, Review, Muscarinic Antagonists, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Aclidinium bromide, Maintenance therapy, aclidinium, Internal medicine, Formoterol Fumarate, medicine, COPD, long-acting muscarinic antagonist, Humans, Pharmacology (medical), 030212 general & internal medicine, long-acting β2-agonist, Adrenergic beta-2 Receptor Agonists, lcsh:RC705-779, biology, maintenance treatment, business.industry, lcsh:Diseases of the respiratory system, Lama, medicine.disease, biology.organism_classification, Obstructive lung disease, 3. Good health, bronchodilators, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, Quality of Life, Formoterol, business, medicine.drug, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2e6e558b3eb232ce3210aff2bd5a26Test
http://europepmc.org/articles/PMC6535700Test